Update on Clinical Trials

Font Resizer

The Eye Consultants Research Foundation is still actively seeking Dallas/Fort Worth area participants for our Light Adjustable Lens (LAL®) clinical study. If you have cataracts you may be eligible for inclusion in this study. Should you qualify and choose to participate, you will be compensated for your time and involvement.


The LAL is designed to allow surgeons to customize the lens power for each eye after cataract or lens replacement surgery, and is the first lens of its kind. Dr. Labor is one of only 15 surgeons nationwide selected to participate in this study by Calhoun Vision, developer of the LAL.

“This technology represents a true breakthrough in the advancement of cataract surgery and IOL technology,” Dr. Labor recently said. “And while this technology is currently under investigation in the U.S., it has been successfully used worldwide for a decade.”

The LAL is similar in many respects to several standard monofocal IOLs (intraocular lenses), so it can be implanted during a normal lens implant procedure. Approximately two to three weeks after surgery, Dr. Labor evaluates the patient’s vision. He can then adjust the lens power to sharpen vision accordingly. This can be repeated in a few days if necessary.

The goal of this study is to evaluate the safety and effectiveness of this lens for treatment of cataracts. We have been very encouraged by the outcomes and very carefully screen any potential candidate for every study.

Visit the Eye Consultants Research Foundation page on our website to learn more about this study. Or simply call 817-410-2030 or email info@eyecontx.com. If you are interested in participating we will be happy to set up an appointment.

The LAL is an investigational device in the U.S., which means it has not yet been approved for sale in the U.S. by the U.S. Food and Drug Administration, and is limited by United States federal law to investigational use only.